Genomic deletions explain the generation of alternative BRAF isoforms conferring resistance to MAPK inhibitors in melanoma
Article in Cell Reports (April 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Roles and mechanisms of aberrant alternative splicing in melanoma — implications for targeted therapy and immunotherapy resistance
Article in Cancer Cell International (March 2024)
Extracellular vesicles as a liquid biopsy for melanoma: Are we there yet?
Article in Seminars in Cancer Biology (January 2023)